When Sydney tech entrepreneur Paul Conyngham was told his 8-year-old rescue dog Rose had terminal cancer, he refused to accept the diagnosis. With no medical background but years of experience in machine learning, he turned to AI tools available to anyone—and achieved what veterinarians thought impossible.
The Diagnosis
Rose had an aggressive form of cancer with a grim prognosis. Traditional treatments weren’t stopping the tumor. Conyngham, who describes Rose as his “best mate” who’s been with him through tough times, decided to take matters into his own hands.
“When she was handed this sentence, I felt I had to do my part for her as well,” he told Australia’s Today program.
The AI-Assisted Solution
Conyngham used a combination of publicly available AI tools to design a personalized mRNA cancer vaccine:
- ChatGPT — For research synthesis, understanding cancer biology, and structuring the vaccine development approach
- AlphaFold — Google’s AI system for predicting protein structures, used to analyze tumor-specific proteins
- Grok — For additional analysis and validation
The process involved sequencing Rose’s tumor DNA, identifying unique mutations (neoantigens), and designing mRNA sequences that would train her immune system to recognize and attack the cancer cells. The same lipid nanoparticle technology used in Pfizer and Moderna COVID vaccines delivered the genetic instructions.
From Design to Reality
Here’s where this story diverges from typical DIY experiments: Conyngham partnered with researchers at two Australian universities and UNSW’s Ramaciotti Centre for Gene Function Analysis to manufacture the vaccine. This wasn’t a garage operation—it was a collaboration between AI-assisted design and established scientific infrastructure.
The result? Rose’s tumor shrank by 75%. What began as a terminal diagnosis became a manageable condition.
Why This Matters for AI Development
This case illustrates several important trends in AI application development:
- Democratization of expertise — AI tools give motivated individuals access to knowledge domains previously requiring years of specialized training
- Human-AI collaboration — The breakthrough came from combining AI research capabilities with human determination and institutional partnerships
- Rapid prototyping — What might have taken months of literature review happened in weeks with AI assistance
For businesses exploring AI integration, the lesson is clear: the barrier to innovation isn’t access to information anymore—it’s the ability to ask the right questions and validate the answers.
The Caveats
Before anyone rushes to replicate this experiment, important context:
- This was a single case, not a clinical trial
- Conyngham had machine learning expertise and university partnerships
- mRNA vaccine manufacturing requires specialized facilities
- Regulatory frameworks for personalized veterinary medicine are unclear
As reported by Newsweek, this represents a world-first in using consumer AI tools for personalized cancer vaccine development—but it’s not a blueprint for DIY medicine.
Broader Implications
This story arrives at a pivotal moment. AI models are becoming capable enough to assist in complex scientific research, but governance frameworks haven’t caught up. The same tools that helped save Rose could theoretically be misused.
For the AI industry, cases like this demonstrate value while highlighting the need for responsible development practices. The technology works—but it requires human judgment, institutional partnerships, and appropriate caution.
What Businesses Should Take Away
Three implications for Australian companies:
- Expertise amplification — AI doesn’t replace domain experts but extends their reach. Consider how AI tools could augment your team’s capabilities
- Partnership opportunities — The most effective AI implementations combine internal expertise with external capabilities
- Regulatory awareness — As AI enables new possibilities, expect increased scrutiny. Build compliance into your AI strategy from day one
At aideveloper.com.au, we’ve been building AI solutions since 2017. Whether you’re exploring AI agent development or conducting an AI business audit, we help organizations navigate this rapidly evolving landscape responsibly.
Want to explore how AI could transform your operations? Contact us for a consultation.
